• Newsletters
  • Gift Membership
Logo Logo
Take Scroll With You Download the app to read our award-winning journalism on the go and stay up-to-date with our notifications.
Get the app Get the app
ANDROID iOS
  • Home
  • Common Ground
  • The India Fix
  • Eco India
  • The Latest
  • The Reel
  • Magazine
  • Video
  • Trending
    • What does Trump’s ceasefire announcement mean for Modi's strongman image?
    • The community that became home: Nine years of Broke Bibliophiles – Bombay Chapter book club
    • From the fall of Islamabad to an attack on Karachi: 5 fake stories that Indian TV news ran with
    • The 2025 Pulitzer Prizes: A readers’ guide to the seven winning books
    • TV coverage of the conflict is rage bait masquerading as news. How did India get here?
    • Why India was unable to stop IMF’s $2.4 billion assistance to Pakistan amid escalating hostilities
    • When cars were still rare, two US women decided to experience India from behind the wheel
    • Why Ola and Uber are copying India’s new ride-hailing app
    • Will new recycling mandate reduce construction waste in India?
    • Why India’s censorship of news media online without stating reasons is unlawful
    • ‘Back from the trenches, more dead than alive’: A poet urges us to reconsider the true cost of war
    • In wake of ceasefire, damaged homes in a Jammu neighbourhood bear witness to human cost of conflict
  • Sections
    • Politics
    • Culture
    • India
    • World
    • Film and TV
    • Music
    • Books and Ideas
    • Business and Economy
    • Science and Technology
    • In Pictures
    • Announcements
    • Bookshop
    • The Field
    • Pulse
    • Elections 2024

DCGI

  • Drug regulators stop production at 18 firms in drive against spurious medicines

    Drug regulators stop production at 18 firms in drive against spurious medicines

    Scroll Staff
    · Mar 28, 2023 · 08:26 pm
  • Tamil Nadu drug controller suspends production at Global Pharma after CDC alert

    Tamil Nadu drug controller suspends production at Global Pharma after CDC alert

    Tabassum Barnagarwala
    · Feb 04, 2023 · 05:34 pm
  • Indian firm recalls eye drops after US flags 55 cases of adverse events, including one death

    Indian firm recalls eye drops after US flags 55 cases of adverse events, including one death

    Tabassum Barnagarwala
    · Feb 03, 2023 · 06:42 pm
  • India’s drug approval system is broken but a proposed new law does nothing to fix it

    India’s drug approval system is broken but a proposed new law does nothing to fix it

    Dinesh Thakur Prashant Reddy T
    · Aug 06, 2022 · 09:00 am
  • Serum Institute of India applies for full market authorisation of Covishield vaccine

    Serum Institute of India applies for full market authorisation of Covishield vaccine

    Scroll Staff
    · Dec 31, 2021 · 06:47 pm
  • Covaxin receives DCGI approval for use in children from 12 to 18 years

    Covaxin receives DCGI approval for use in children from 12 to 18 years

    Scroll Staff
    · Dec 26, 2021 · 08:15 am
  • Covid-19: Biological E gets DCGI approval to conduct phase 2, 3 vaccine trials on children

    Covid-19: Biological E gets DCGI approval to conduct phase 2, 3 vaccine trials on children

    Scroll Staff
    · Sep 03, 2021 · 09:34 pm
  • Coronavirus: Bharat Biotech vaccine approved in clinical trial mode, clarifies ICMR

    Coronavirus: Bharat Biotech vaccine approved in clinical trial mode, clarifies ICMR

    Scroll Staff
    · Jan 06, 2021 · 11:01 am
  • Coronavirus: Congress questions Covaxin’s approval before completing phase-3 trials

    Coronavirus: Congress questions Covaxin’s approval before completing phase-3 trials

    Scroll Staff
    · Jan 03, 2021 · 03:09 pm
  • Coronavirus: Serum Institute gets drugs regulator approval to resume India trials of Oxford vaccine

    Coronavirus: Serum Institute gets drugs regulator approval to resume India trials of Oxford vaccine

    Scroll Staff
    · Sep 16, 2020 · 10:35 am